News
Seoul, Seoul / Syndication Cloud / July 13, 2025 / Lydian Cosmetic Surgery Clinic Key Takeaways: Orthopedic non-invasive stem ...
Systemic sclerosis (SSc) is a chronic autoimmune disease characterized by systemic inflammation, fibrosis, vascular injury, reduced quality of life, and limited treatment options. Autologous ...
Dr. Matthew Ku discusses what CAR T-cell therapy is and how it works to target diseases like myelofibrosis.
Based on that criterion, ten out of 12 people (83%) in a new clinical trial were cured of their diabetes one year after receiving an advanced stem cell therapy.
A CAR T-cell therapy from Iaso Biotherapeutics was tolerated well and led to marked improvements in disability for three people with progressive forms of multiple sclerosis (MS), according to ...
Duke and Cryo-Cell, an umbilical cord blood and cord tissue stem cell bank, had nearly five years of exclusive partnership. Leading up to the termination, both parties claimed the other breached ...
Diabetic woman no longer needs insulin after single stem cell treatment — why it’s not given to everyone with diabetes By Diana Bruk Published June 23, 2025, 7:38 p.m. ET ...
T cells transformed in vivo to target B cells could widen the scope of diseases treated by chimeric antigen receptor T-cell therapy.
Stem Cell-Based Treatment with Safety Switch Shows Potential for Patients with Type 1 Diabetes Findings demonstrating the early-stage success of genetically modified stem cell-derived islet (SC-islet) ...
Zemcelpro provides an option for people with a hematologic malignancy who need a blood stem cell transplant but have no suitable donor.
Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results